Deniz Kumbasar

Deniz Kumbasar

Auto-generated profile, based on publicly available information

Deniz Kumbasar

Cardiology Department, Ankara University Medical School, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2002 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
IDIrem Dincer
Irem Dincer
DKDeniz Kumbasar
Deniz Kumbasar
GNGökhan Nergisoglu
Gökhan Nergisoglu
YAYusuf Atmaca
Yusuf Atmaca
SKSim Kutlay
Sim Kutlay
DODervis Oral
Dervis Oral

1 September 2009 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
BCBasar Candemir
Basar Candemir
DKDeniz Kumbasar
Deniz Kumbasar
STSibel Turhan
Sibel Turhan
MKMustafa Kilickap
Mustafa Kilickap
COCagdas Ozdol
Cagdas Ozdol
TATimucin Altin
Timucin Altin

1 September 2005 in The American Journal of Cardiology
Verified
Journal Article
Closed access
YAYusuf Atmaca
Yusuf Atmaca
AOAydan Ongun Ozdemir
Aydan Ongun Ozdemir
COCagdas Ozdol
Cagdas Ozdol
DODidem Oguz
Didem Oguz
SGSadi Gulec
Sadi Gulec
CECetin Erol
Cetin Erol

1 October 2007 in Angiology
Verified
Journal Article
Closed access
PDF file
DKDeniz Kumbasar
Deniz Kumbasar
ÖAÖmer Akyürek
Ömer Akyürek
IDIrem Dincer
Irem Dincer
YAYusuf Atmaca
Yusuf Atmaca
MKMustafa Kılıçkap
Mustafa Kılıçkap
DODerviş Oral
Derviş Oral
The authors undertook this study to see whether highly developed coronary collaterals at an area shed by a totally occluded coronary artery predicts myocardial viability. Percutaneous coronary intervention (PCI) of a totally occluded coronary artery has been debated since its introduction. It is recommended to search for viable myocardium before opening a totally occluded coronary artery; however, there is no practical yet sensitive method of assessing myocardial viability in the catheterization laboratory. Forty-seven consecutive patients (12 women, 25.5%; 35 men, 74.5%), each with 1 totally occluded coronary artery, were prospectively enrolled to the study. After the diagnostic coronary angiography, all patients underwent dobutamine stress echocardiography to determine viable myocardium at the territory of the totally occluded coronary artery, and the status of angiographic coronary collaterals was assessed. Patients were then divided into 2 groups according to the presence (Group A) or absence (Group B) of viable myocardium by stress echocardiography. Eighteen patients (38.3%) had viable myocardium (Group A) in the area shed by the totally occluded coronary artery and 29 patients (61.7%) had nonviable myocardium (Group B). The incidences of significant coronary collateral circulation to the viable (Group A) and nonviable (Group B) areas were 66.7% (12 patients) and 20.7% (6 patients), respectively (p = 0.002). Logistic regression analysis was used to evaluate the independent factors for viable myocardium, and only significant coronary collateral circulation was found to be an independent factor for the detection of viable myocardium (p = 0.006, OR 16.7, 95% CI 2.25 to 124.4). The sensitivity and specificity of good collateral circulation for the detection of viable myocardium were 75% and 65.7%, respectively. The positive predictive and negative predictive values of the good coronary collateral circulation in detecting viable myocardium were 75% and 79%, respectively. The authors conclude that good coronary collaterals have a high sensitivity and positive predictive value for the prediction of viability as shown by dobutamine echocardiography, and only by assessing the coronary collateral circulation can one decide for percutaneous coronary revascularization, if not for coronary artery bypass surgery.

1 September 2006 in Coronary Artery Disease
Verified
Journal Article
Closed access
IDIrem Dncer
Irem Dncer
AOAydan Ongun
Aydan Ongun
STSibel Turhan
Sibel Turhan
COCagdas Ozdol
Cagdas Ozdol
DKDeniz Kumbasar
Deniz Kumbasar
CECetin Erol
Cetin Erol
The coronary collateral circulation is an alternative source of blood supply to myocardium in the presence of advanced coronary artery disease and the therapeutic promotion of collateral growth appears to be a valuable treatment strategy in these patients. Although it has been shown in in-vivo studies that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) promote vasculogenesis and accelerate coronary collateral development in ischemic tissues, there are discordant results in clinical studies. Our aim was to investigate the effect of statin therapy, including dosage and duration of treatment, on coronary collateral growth in patients with advanced coronary artery disease. Study population consisted of 400 (306 men, with the mean age of 62+/-10 years) consecutive patients who have undergone clinically indicated coronary angiography and had at least one major coronary artery stenosis of > or =95%. Coronary collaterals were graded from 0 to 3 according to the Cohen-Rentrop method and patients with grade 0-1 collateral development were regarded as having poor collateral and patients with grade 2-3 collateral development were regarded as having good collateral. Among 400 patients, 196 (48%) were on statin therapy. Patients with good collateral score were more likely to have stable angina pectoris as clinical presentation (P or =10 mg atorvastatin-equivalent dose had better collateral development (P or =10 mg atorvastatin-equivalent dose [odds ratio 2.06, 95% confidence interval (1.3-2.6), P or =10 mg atorvastatin-equivalent dose), stable angina pectoris and having multivessel disease are associated with enhanced coronary collateral development in patients with advanced coronary artery disease.

9 July 2020 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
MÇMehtap Bilgin Çetin
Mehtap Bilgin Çetin
CÖCanan Önder
Canan Önder
KOKaan Orhan
Kaan Orhan
DKDeniz Kumbasar
Deniz Kumbasar
MSMuhittin Abdülkadir Serdar
Muhittin Abdülkadir Serdar
EÜElif Ünsal
Elif Ünsal